XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (4984)	12/3/1997 3:25:00 PM
From: Pseudo Biologist	Read Replies (2) of 17367

george, I read the AOL Xoma board last night and someone there has claimed to have had a reply to an e-mail to Giroir (or some other author of the Lancet paper). In this reply this author is alleged to have said to be preparing a "counter-letter" to Duncan's and to have also said that Dr. Duncan is mistaken (or something to that effect) in his comments. On the modus operandi of medical journals, and others like Science or Nature. Usually a small fraction of papers in each issue carries an accompanying comment, news and views or "editorial" piece; the author(s) of these pieces get advanced copies of the articles commented upon. It is not uncommon to see the accompanying piece appear one or two issues after the original paper was published (esp. if the publications are weekly or bi-weekly). I've noticed (and this is purely anecdotal) that the editorials/commentaries tend to be cheerleader-like in Nature or Science, but kind of skeptical in Lancet or New England Journal. PB (not an author)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next